Organizing Pneumonia Reported After Ocrelizumab in Multiple Sclerosis
A case report and literature review describe organizing pneumonia after ocrelizumab therapy in multiple sclerosis, raising attention to rare pulmonary toxicity.
From stroke to neurodegeneration — the science and its clinical impact.
From stroke to neurodegeneration — the science and its clinical impact.